Strategies to control antipsychotic-induced weight gain.
Kapoor
Shailendra
S
University of Illinois at Chicago, Chicago, IL, USA. shailendrakapoor@yahoo.com
D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001364:Awareness / Q000502:physiology; D001835:Body Weight / Q000187:drug effects / Q000502:physiology; D016642:Bupropion / Q000627:therapeutic use; D002983:Clinical Competence; D005632:Fructose / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008550:Melatonin / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use; D009765:Obesity / Q000139:chemically induced* / Q000517:prevention & control*; D000077236:Topiramate; D016896:Treatment Outcome; D015430:Weight Gain / Q000187:drug effects*
D019440:Anti-Obesity Agents; D014150:Antipsychotic Agents; D007004:Hypoglycemic Agents; D016642:Bupropion; D000077236:Topiramate; D005632:Fructose; D008687:Metformin; D008550:Melatonin